Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon.

Fernández de Marco Mdel M, Alejo A, Hudson P, Damon IK, Alcami A.

FASEB J. 2010 May;24(5):1479-88. doi: 10.1096/fj.09-144733. Epub 2009 Dec 17.

2.

Properties of the recombinant TNF-binding proteins from variola, monkeypox, and cowpox viruses are different.

Gileva IP, Nepomnyashchikh TS, Antonets DV, Lebedev LR, Kochneva GV, Grazhdantseva AV, Shchelkunov SN.

Biochim Biophys Acta. 2006 Nov;1764(11):1710-8. Epub 2006 Sep 19.

PMID:
17070121
3.

Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection.

Estep RD, Messaoudi I, O'Connor MA, Li H, Sprague J, Barron A, Engelmann F, Yen B, Powers MF, Jones JM, Robinson BA, Orzechowska BU, Manoharan M, Legasse A, Planer S, Wilk J, Axthelm MK, Wong SW.

J Virol. 2011 Sep;85(18):9527-42. doi: 10.1128/JVI.00199-11. Epub 2011 Jul 13.

4.

Monkeypox virus and insights into its immunomodulatory proteins.

Weaver JR, Isaacs SN.

Immunol Rev. 2008 Oct;225:96-113. doi: 10.1111/j.1600-065X.2008.00691.x. Review.

5.

[Comparative study of variola virus and monkeypox virus interferon-gamma-binding].

Nepomniashchikh TS, Lebedev LR, Riazankin IA, Pozdniakov SG, Gileeva IP, Shchelkunov SN.

Mol Biol (Mosk). 2005 Nov-Dec;39(6):1055-62. Russian.

PMID:
16358743
6.

Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections.

Gilchuk I, Gilchuk P, Sapparapu G, Lampley R, Singh V, Kose N, Blum DL, Hughes LJ, Satheshkumar PS, Townsend MB, Kondas AV, Reed Z, Weiner Z, Olson VA, Hammarlund E, Raue HP, Slifka MK, Slaughter JC, Graham BS, Edwards KM, Eisenberg RJ, Cohen GH, Joyce S, Crowe JE Jr.

Cell. 2016 Oct 20;167(3):684-694.e9. doi: 10.1016/j.cell.2016.09.049.

7.

Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.

Stittelaar KJ, Neyts J, Naesens L, van Amerongen G, van Lavieren RF, HolĂ˝ A, De Clercq E, Niesters HG, Fries E, Maas C, Mulder PG, van der Zeijst BA, Osterhaus AD.

Nature. 2006 Feb 9;439(7077):745-8. Epub 2005 Dec 11.

PMID:
16341204
8.

Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.

Arndt WD, Cotsmire S, Trainor K, Harrington H, Hauns K, Kibler KV, Huynh TP, Jacobs BL.

J Virol. 2015 Oct;89(20):10489-99. doi: 10.1128/JVI.00304-15. Epub 2015 Aug 5.

9.

Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models.

Americo JL, Moss B, Earl PL.

J Virol. 2010 Aug;84(16):8172-80. doi: 10.1128/JVI.00621-10. Epub 2010 Jun 2.

10.

Elucidating the role of the complement control protein in monkeypox pathogenicity.

Hudson PN, Self J, Weiss S, Braden Z, Xiao Y, Girgis NM, Emerson G, Hughes C, Sammons SA, Isaacs SN, Damon IK, Olson VA.

PLoS One. 2012;7(4):e35086. doi: 10.1371/journal.pone.0035086. Epub 2012 Apr 9.

11.

Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation.

Realegeno S, Puschnik AS, Kumar A, Goldsmith C, Burgado J, Sambhara S, Olson VA, Carroll D, Damon I, Hirata T, Kinoshita T, Carette JE, Satheshkumar PS.

J Virol. 2017 May 12;91(11). pii: e00011-17. doi: 10.1128/JVI.00011-17. Print 2017 Jun 1.

12.

Outbreaks of human monkeypox after cessation of smallpox vaccination.

Reynolds MG, Damon IK.

Trends Microbiol. 2012 Feb;20(2):80-7. doi: 10.1016/j.tim.2011.12.001. Epub 2012 Jan 10. Review.

PMID:
22239910
13.

Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques.

Denzler KL, Babas T, Rippeon A, Huynh T, Fukushima N, Rhodes L, Silvera PM, Jacobs BL.

Vaccine. 2011 Dec 6;29(52):9684-90. doi: 10.1016/j.vaccine.2011.09.135. Epub 2011 Oct 12.

14.

Human monkeypox and smallpox viruses: genomic comparison.

Shchelkunov SN, Totmenin AV, Babkin IV, Safronov PF, Ryazankina OI, Petrov NA, Gutorov VV, Uvarova EA, Mikheev MV, Sisler JR, Esposito JJ, Jahrling PB, Moss B, Sandakhchiev LS.

FEBS Lett. 2001 Nov 30;509(1):66-70.

15.

A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus.

Stabenow J, Buller RM, Schriewer J, West C, Sagartz JE, Parker S.

J Virol. 2010 Apr;84(8):3909-20. doi: 10.1128/JVI.02012-09. Epub 2010 Feb 3.

16.

Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations.

Townsend MB, Keckler MS, Patel N, Davies DH, Felgner P, Damon IK, Karem KL.

J Virol. 2013 Jan;87(2):900-11. doi: 10.1128/JVI.02089-12. Epub 2012 Nov 7.

17.

Monkeypox disease transmission in an experimental setting: prairie dog animal model.

Hutson CL, Carroll DS, Gallardo-Romero N, Weiss S, Clemmons C, Hughes CM, Salzer JS, Olson VA, Abel J, Karem KL, Damon IK.

PLoS One. 2011;6(12):e28295. doi: 10.1371/journal.pone.0028295. Epub 2011 Dec 2.

18.

A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27.

Hughes LJ, Goldstein J, Pohl J, Hooper JW, Lee Pitts R, Townsend MB, Bagarozzi D, Damon IK, Karem KL.

Virology. 2014 Sep;464-465:264-273. doi: 10.1016/j.virol.2014.06.039. Epub 2014 Aug 9.

19.

Attenuation of monkeypox virus by deletion of genomic regions.

Lopera JG, Falendysz EA, Rocke TE, Osorio JE.

Virology. 2015 Jan 15;475:129-38. doi: 10.1016/j.virol.2014.11.009. Epub 2014 Dec 1.

20.

Supplemental Content

Support Center